Boku N - Search Results

1

A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.

Izawa N, Masuishi T, Takahashi N, Shoji H, Yamamoto Y, Matsumoto T, Sugiyama K, Kajiwara T, Kawakami K, Aomatsu N, Kondoh C, Kawakami H, Takegawa N, Esaki T, Shimokawa M, Nishio K, Narita Y, Hara H, Sunakawa Y, Boku N, Moriwaki T, Eguchi Nakajima T, Muro K. Izawa N, et al. Among authors: boku n. Target Oncol. 2023 May;18(3):369-381. doi: 10.1007/s11523-023-00963-9. Epub 2023 May 6. Target Oncol. 2023. PMID: 37148491 Clinical Trial.

2

Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.

Muro K, Ohtsu A, Boku N, Chin K, Oda Y, Fujii T, Hosokawa K, Yoshida S, Hasebe T. Muro K, et al. Among authors: boku n. Jpn J Clin Oncol. 1996 Apr;26(2):65-9. doi: 10.1093/oxfordjournals.jjco.a023186. Jpn J Clin Oncol. 1996. PMID: 8609696 Clinical Trial.

3

Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.

Shirao K, Shimada Y, Kondo H, Saito D, Yamao T, Ono H, Yokoyama T, Fukuda H, Oka M, Watanabe Y, Ohtsu A, Boku N, Fujii T, Oda Y, Muro K, Yoshida S. Shirao K, et al. Among authors: boku n. J Clin Oncol. 1997 Mar;15(3):921-7. doi: 10.1200/JCO.1997.15.3.921. J Clin Oncol. 1997. PMID: 9060529 Clinical Trial.

4

An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.

Ohtsu A, Boku N, Tamura F, Muro K, Shimada Y, Saigenji K, Akazawa S, Kitajima M, Kanamaru R, Taguchi T. Ohtsu A, et al. Among authors: boku n. Am J Clin Oncol. 1998 Aug;21(4):416-9. doi: 10.1097/00000421-199808000-00021. Am J Clin Oncol. 1998. PMID: 9708646 Clinical Trial.

5

Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae.

Muto M, Ohtsu A, Miyamoto S, Muro K, Boku N, Ishikura S, Satake M, Ogino T, Tajiri H, Yoshida S. Muto M, et al. Among authors: boku n. Cancer. 1999 Oct 15;86(8):1406-13. Cancer. 1999. PMID: 10526266

6

Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.

Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A. Ohtsu A, et al. Among authors: boku n. J Clin Oncol. 1999 Sep;17(9):2915-21. doi: 10.1200/JCO.1999.17.9.2915. J Clin Oncol. 1999. PMID: 10561371

7

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.

Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T. Muro K, et al. Among authors: boku n. Ann Oncol. 2004 Jun;15(6):955-9. doi: 10.1093/annonc/mdh231. Ann Oncol. 2004. PMID: 15151954 Free article. Clinical Trial.

8

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.

Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL. Shirao K, et al. Among authors: boku n. J Clin Oncol. 2004 Sep 1;22(17):3466-74. doi: 10.1200/JCO.2004.05.017. Epub 2004 Jul 26. J Clin Oncol. 2004. PMID: 15277535 Clinical Trial.

9

Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.

Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K. Yamada Y, et al. Among authors: boku n. Jpn J Clin Oncol. 2006 Apr;36(4):218-23. doi: 10.1093/jjco/hyl020. Jpn J Clin Oncol. 2006. PMID: 16684860 Clinical Trial.

10

Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors.

Shirao K, Matsumura Y, Yamada Y, Muro K, Gotoh M, Boku N, Ohtsu A, Nagashima F, Sano Y, Mutoh M, Tanigawara Y. Shirao K, et al. Among authors: boku n. Jpn J Clin Oncol. 2006 May;36(5):295-300. doi: 10.1093/jjco/hyl016. Epub 2006 May 15. Jpn J Clin Oncol. 2006. PMID: 16702162 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

490 results

Search Page